Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-1998 | 08-1997 | 08-1996 | 08-1995 | 08-1994 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -300 | -380 | -380 | -340 | -1,200 |
| Depreciation Amortization | 40 | 30 | 40 | 40 | 40 |
| Other Working Capital | -4 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 14 | 90 | -50 | -110 | 710 |
| Operating Cash Flow | $-250 | $-260 | $-390 | $-410 | $-450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 250 | 150 | -100 | 880 | 530 |
| Investing Cash Flow | $210 | $150 | $-100 | $880 | $530 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -10 | 90 | 0 | -10 | -100 |
| Financing Cash Flow | $-10 | $90 | $N/A | $-10 | $-100 |
| Beginning Cash Position | 400 | 420 | 910 | 470 | 490 |
| End Cash Position | 350 | 400 | 420 | 910 | 470 |
| Net Cash Flow | $-50 | $-10 | $-490 | $440 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -250 | -260 | -390 | -410 | -450 |
| Free Cash Flow | -250 | -260 | -390 | -410 | -450 |